-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – SXC-2023
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry SXC-2023 Drug Details SXC-2023 is under development for the treatment of neuro-psychiatric disorder such...
-
Product Insights
Trichotillomania Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Trichotillomania Global Clinical Trials Review, H2, 2018" provides an overview of Trichotillomania clinical trials scenario. This report provides top line data relating to the clinical trials on Trichotillomania. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...